The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib

Journal article

Peer reviewed

J. S Khorashad, M Anand, J Kaeda, D Marin, S Saunders, T AL-JABARY, A Iqbal, S Margerison, J. V Melo, J. M Goldman, …

Leukemia, Vol.20(4), pp.658-663

01/04/2006

PMID: 16467863

Abstract

Biological and medical sciences

Hematologic and hematopoietic diseases

Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Medical sciences

1 Record Views

Title: The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib
Creators - without role: J. S Khorashad - Hammersmith Hospital
M Anand - Hammersmith Hospital
J Kaeda - Hammersmith Hospital
D Marin - Hammersmith Hospital
S Saunders - Hammersmith Hospital
T AL-JABARY - Hammersmith Hospital
A Iqbal - Hammersmith Hospital
S Margerison - Biotage
J. V Melo - Hammersmith Hospital
J. M Goldman - Imperial College London
J. F Apperley - Imperial College London
Publication Details: Leukemia, Vol.20(4), pp.658-663
Publisher: Nature Publishing
Identifiers: 9949640808331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article